Foamix Pharmaceuticals Ltd.·4

Nov 20, 4:05 PM ET

Howard Alvin D 4

4 · Foamix Pharmaceuticals Ltd. · Filed Nov 20, 2018

Insider Transaction Report

Form 4
Period: 2018-11-19
Howard Alvin D
VP Regulatory
Transactions
  • Sale

    Ordinary Shares

    2018-11-19$3.90/sh3,375$13,16338,414 total
Footnotes (1)
  • [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. This sale is mandated by the Issuer's non-discretionary policy that requires the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Documents

1 file
  • 4
    zk1822312.xmlPrimary

    OWNERSHIP DOCUMENT